CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net income		$ 426	$ 363
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income taxes		(80)	(63)
Provision for inventories		1	11
Depreciation and amortization		224	107
Amortization of capitalized software development costs and intellectual property licenses	[1]	89	124
Amortization of debt discount, financing costs, and non-cash write-off due to extinguishment of debt		7	4
Share-based compensation expense	[2]	33	34
Other		14	0
Changes in operating assets and liabilities, net of effect from business acquisitions:
Accounts receivable, net		396	459
Inventories		2	14
Software development and intellectual property licenses		(67)	(104)
Other assets		(3)	83
Deferred revenues		(494)	(508)
Accounts payable		(76)	(184)
Accrued expenses and other liabilities		(61)	(3)
Net cash provided by operating activities		411	337
Cash flows from investing activities:
Acquisition of King, net of cash acquired (see Note 14)		0	(4,588)
Release of cash in escrow		0	3,561
Capital expenditures		(21)	(27)
Other investing activities		(2)	(14)
Net cash used in investing activities		(23)	(1,068)
Cash flows from financing activities:
Proceeds from issuance of common stock to employees		109	24
Tax payment related to net share settlements on restricted stock units		(13)	(11)
Proceeds from debt issuances, net of discounts		2,551	2,520
Repayment of long-term debt		(3,051)	(750)
Debt financing costs related to debt issuances		0	(4)
Net cash (used in) provided by financing activities		(404)	1,779
Effect of foreign exchange rate changes on cash and cash equivalents		19	1
Net increase in cash and cash equivalents		3	1,049
Cash and cash equivalents at beginning of period		3,245	1,823
Cash and cash equivalents at end of period		$ 3,248	$ 2,872

[1] Excludes deferral and amortization of share-based compensation expense.

[2] Includes the net effects of capitalization, deferral, and amortization of share-based compensation expense.